We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+2.79%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$14.6B
AUM Growth
-$1.84B
Cap. Flow
-$1.86B
Cap. Flow %
-12.78%
Top 10 Hldgs %
34.48%
Holding
2,201
New
633
Increased
437
Reduced
361
Closed
764

Top Buys

Rank Stock Value
1
DUK icon
Duke Energy
DUK
+$172M
2
CVX icon
Chevron
CVX
+$99.4M
3
AAPL icon
Apple
AAPL
+$91.7M
4
EVRG icon
Evergy
EVRG
+$89M
5
ED icon
Consolidated Edison
ED
+$86.6M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$412M
2
MDLZ icon
Mondelez International
MDLZ
+$131M
3
JNJ icon
Johnson & Johnson
JNJ
+$107M
4
NI icon
NiSource
NI
+$88.5M
5
PPL
PPL Corp
PPL
+$86.4M

Sector Composition

Rank Sector Weight
1 Financials 9.81%
2 Technology 9.77%
3 Healthcare 7.98%
4 Utilities 7.37%
5 Real Estate 5.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MGX icon
2151
Metagenomi Therapeutics
MGX
$46.5M
-280,287
Closed -$608K
SMXT icon
2152
Solarmax Technology
SMXT
$17.3M
-15,154
Closed -$115K
ALAB icon
2153
CALL
Astera Labs
ALAB
$49.4B
-105,000
Closed -$5.52M
ALAB icon
2154
Astera Labs
ALAB
$49.4B
-42,291
Closed -$2.22M
GCTS
2155
GCT Semiconductor Holding
GCTS
$188M
-25,335
Closed -$85K
BOLD
2156
Boundless Bio
BOLD
$68.2M
-17,328
Closed -$60K
SKYE icon
2157
Skye Bioscience
SKYE
$1.24M
-24,552
Closed -$96K
TE
2158
T1 Energy
TE
$1.3B
-554,092
Closed -$538K
TEN
2159
Tsakos Energy Navigation Ltd
TEN
$1.29B
-53,346
Closed -$1.34M
AIOT
2160
PowerFleet Inc
AIOT
$408M
-17,134
Closed -$86K
GAP
2161
The Gap Inc
GAP
$7.13B
-42,409
Closed -$935K
INVX
2162
Innovex International
INVX
$2.05B
-113,276
Closed -$1.66M
BKV
2163
BKV Corp
BKV
$2.65B
-74,120
Closed -$1.36M
GRDN
2164
Guardian Pharmacy Services
GRDN
$2.4B
-11,322
Closed -$190K
ONC
2165
BeOne Medicines Ltd
ONC
$42.4B
-13,600
Closed -$3.05M
NAGE
2166
Niagen Bioscience
NAGE
$254M
-39,900
Closed -$146K
JOYY
2167
JOYY Inc
JOYY
$3.71B
-7,189
Closed -$261K
TPC
2168
Tutor Perini Cor
TPC
$4.8B
-28,009
Closed -$761K
BECN
2169
DELISTED
Beacon Roofing Supply, Inc.
BECN
-7,986
Closed -$690K
FFNW
2170
DELISTED
First Financial Northwest, Inc
FFNW
-15,669
Closed -$353K
EQC
2171
DELISTED
Equity Commonwealth
EQC
-75,160
Closed -$1.5M
PYCR
2172
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
-357,470
Closed -$5.07M
LGTY
2173
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
-35,628
Closed -$399K
PTVE
2174
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
-14,428
Closed -$166K
SYRS
2175
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
-313,004
Closed -$673K

Similar funds

Michael Gelband's Q4 2024 Portfolio in Review

As of Q4 2024, Michael Gelband held 2,201 positions worth $14.6B, down 11% from $16.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Michael Gelband withdrew a net $1.86B in Q4 2024, closing 764 positions and reducing 361 holdings. Its most notable exit was Mondelez International, an estimated $131M position sold in full.

By sector, the portfolio is most concentrated in Financials at 9.8% of assets, up from 4.6% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Michael Gelband opened a new position in Duke Energy worth $164M.

  • Michael Gelband's largest Q4 2024 buy was Duke Energy: 1,520,504 shares worth $164M.
  • Michael Gelband added most to Chevron in Q4 2024, an estimated $99.4M increase.
  • Michael Gelband's biggest Q4 2024 reduction was Microsoft, cutting an estimated $412M.
  • Michael Gelband fully exited Mondelez International in Q4 2024, selling an estimated $131M.
  • Michael Gelband's ten largest holdings make up 34% of its $14.6B portfolio in Q4 2024.
  • Michael Gelband opened 633 new positions and closed 764 in Q4 2024.
  • Michael Gelband's portfolio value fell 11% quarter-over-quarter to $14.6B.

Based on ExodusPoint Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.